DuPont Agriculture & Nutrition On Track for Strong 2007

DES MOINES (Map) - DES MOINES, Iowa, Dec. 3 /PRNewswire-FirstCall/ -- DuPont Group Vice President J. Erik Fyrwald today said that the company's Agriculture & Nutrition business platform is on track with its previously announced August financial forecast for the full year 2007, positioning the business for solid 2008 financial performance. Fyrwald's comments came during a business review series conference call with investment analysts.

"DuPont Agriculture & Nutrition is on track to increase revenue and earnings by more than 10 percent this year," Fyrwald said. He noted that the biggest gains are coming from an anticipated 15 percent increase in seed sales by the Pioneer Hi-Bred business, based on increased global corn acres and strong results from international operations.

"With our positive momentum in North America and around the world, we are targeting to generate double-digit earnings growth through the foreseeable future," Fyrwald said. "Our rich product pipeline will continue to feed that growth with the release of new technologies each year."

The company is on track to launch Rynaxypyr(TM) insecticide and disease resistant corn in 2008; Optimum(TM) GAT(TM) soybeans and high oleic soybeans in 2009, and; Optimum GAT corn in 2010. Other key traits that will follow include drought tolerance, increased yields and nitrogen use efficiency. DuPont introduced Accelerated Yield Technology (AYT(TM)) in soybeans in 2007.

Fyrwald outlined the company's plan to continue growing its Agriculture & Nutrition businesses. In addition to growth from robust research pipelines at its Crop Protection and Pioneer businesses and majority-owned joint venture Solae, DuPont expects significant growth gains in Latin America, Europe, Africa and Asia.

"DuPont has been aggressively establishing businesses and business relationships in key markets around the world," Fyrwald said. "While we will grow our business in North America, the fastest growth will come from key emerging markets like Brazil, India, eastern Europe and China."

DuPont also announced a joint venture with a Chinese biotech research firm to strengthen its trait discovery research efforts and expand its seed presence in the Chinese market.

A replay of today's conference call can be found at the Investor Center on the company's website at http://www.dupont.com.

DuPont (NYSE: DD) is a science-based products and services company. Founded in 1802, DuPont puts science to work by creating sustainable solutions essential to a better, safer, healthier life for people everywhere. Operating in more than 70 countries, DuPont offers a wide range of innovative products and services for markets including agriculture and food; building and construction; communications; and transportation.

Forward-Looking Statements: This news release contains forward-looking statements based on management's current expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the company's strategy for growth, product development, market position, expected expenditures and financial results are forward-looking statements. Some of the forward-looking statements may be identified by words like "expects," "anticipates," "plans," "intends," "projects," "indicates," and similar expressions. These statements are not guarantees of future performance and involve a number of risks, uncertainties and assumptions. Many factors, including those discussed more fully elsewhere in this release and in DuPont's filings with the Securities and Exchange Commission, particularly its latest annual report on Form 10-K, as well as others, could cause results to differ materially from those stated. These factors include, but are not limited to changes in the laws, regulations, policies and economic conditions of countries in which the company does business; competitive pressures; successful integration of structural changes, including acquisitions, divestitures and alliances; research and development of new products, including regulatory approval and market acceptance, and seasonality of sales of agricultural products.